Brokerage Firm Rating on Cardinal Health (CAH)

Cardinal Health (CAH) : 6 brokerage houses believe that Cardinal Health (CAH) is a Strong Buy at current levels. 6 analysts believe that the current prices are in a balance with the stocks fundamentals, hence they propose Hold on Cardinal Health (CAH). Zacks Investment Research suggests a Hold with a rank of 3.The median of all the 12 Wall Street Analysts endorse the stock as a Buy with a rating of 2.

Cardinal Health (CAH) : 10 Wall Street analysts covering Cardinal Health (CAH) believe that the average level the stock could reach for the short term is $95.4. The maximum price target given is $111 and the minimum target for short term is around $86, hence the standard deviation is calculated at $7.2.


For the current week, the company shares have a recommendation consensus of Buy. Cardinal Health (NYSE:CAH): During Thursdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $83.69 and $82.65 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $83.73. The buying momentum continued till the end and the stock did not give up its gains. It closed at $83.61, notching a gain of 0.07% for the day. The total traded volume was 1,175,952 . The stock had closed at $83.55 on the previous day.

In a related news, The Securities and Exchange Commission has divulged that Watkins Carole S, officer (Chief HR Officer) of Cardinal Health Inc, had unloaded 84,617 shares at an average price of $77.33 in a transaction dated on May 20, 2016. The total value of the transaction was worth $6,543,433.

Cardinal Health, Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States, the Companys Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers, hospitals and other healthcare providers. In China, the Pharmaceutical segment distributes branded, generic and specialty pharmaceutical, over-the-counter healthcare and consumer products, provides logistics, marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical, surgical and laboratory products and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.